2021 PLENARY KEYNOTE SESSIONS
MONDAY, SEPTEMBER 20 | 4:15 PM - 5:45 PM
Lita Sands, Head, Life Sciences, AWS
Innovative Practices Awards - Winners Spotlight
PANEL DISCUSSION: Pharma Executive Roundtable: Broadening the Data Ecosystem
Lita Sands, Head, Life Sciences, AWS
The Bio-IT World community employed creativity, problem solving, and technical ingenuity to weather 2020 and never was the work more important. Meanwhile, digitization has been
broadening the horizons of new possibilities and initiatives that are driving innovation in the life sciences sector. While over the past year many pharmaceutical companies have seen an acceleration of digital transformation, there are still many
that are unsure what to expect going forward. Digital transformation is now a strategic imperative, not a buzzword. Join our Pharma Executive Roundtable to discover how biopharma companies are broadening their digital strategies and capabilities to
develop products and services to scale, streamline operations, and drive innovation in life sciences R&D.
Ramesh V. Durvasula, PhD, Vice President & Information Officer, Research Labs, Eli Lilly & Co.
Michael Montello, Senior Vice President, R&D Tech, GlaxoSmithKline
Bryn Roberts, PhD, Senior Vice President & Global Head of Data Services, Roche
Holly Soares, PhD, Vice President & Head, Precision Medicine, Pfizer Inc.
Lihua Yu, PhD, President and Chief Data Science Officer, H3 Biomedicine, Inc.
TUESDAY, SEPTEMBER 21 | 1:00 PM - 2:30 PM
Michael Stapleton, PhD, Managing Director, Life Sciences, Accenture
How Digital Evolution and an Attitudinal Revolution are Re-Shaping the Future of the Life Sciences Industry
Nimita Limaye, PhD, Research Vice President, Life Sciences R&D Strategy and Technology, IDC
The world has rapidly transitioned to a model of disaggregated care and decentralized
clinical trials, with a heightened focus on patient-centricity. Digital resiliency has become the priority and discretionary spend on R&D platforms has been delayed. Federated-learning models are fueling co-innovation and GPU-powered transformer
models are accelerating drug discovery. Technology is enabling access and equity. The borders between healthcare and life sciences are blurring and real-world data is being leveraged to drive a precision medicine strategy.
All of Us Research Program – Seeking To Advance Precision Health for All Populations
Joshua Denny, MD, MS, CEO, All of Us Research Program, National Institutes of Health
The All of Us Research Program launched May 6, 2018 and currently has over 375,000 participants who have contributed biospecimens,
health surveys, and a willingness to share their EHR. Participants are partners in the program and receive research results from data they contribute, including genetic ancestry and traits. In the future, participants will also receive health-related
genomic results from whole genome sequencing. In May 2020, the program launched the beta version of the Researcher Workbench. Once researchers register and are approved to use the workbench, they can access individual-level data and a suite of tools
to analyze these data. All of Us is committed to catalyzing a robust ecosystem of researchers and providing a rich dataset that drives discovery and improves health.
WEDNESDAY, SEPTEMBER 22 | 2:00 PM - 3:30 PM
Saji Wickramasekara, CEO, Benchling
Ashu Singhal, President & Co-Founder, Benchling
PANEL DISCUSSION: Trends from the Trenches
Kevin Davies, PhD, Executive Editor, The CRISPR Journal; Founding Editor, Bio-IT World
Since 2010, the “Trends from the Trenches” presentation, given by Chris Dagdigian, has been one of the most popular
annual traditions on the Bio-IT Program. The intent of the talk is to deliver a candid (and occasionally blunt) assessment of the best, the worthwhile, and the most overhyped information technologies (IT) for life sciences. The presentation has helped
scientists, leadership, and IT professionals understand the basic topics related to computing, storage, data transfer, networks, cloud, data science, and machine learning that are involved in supporting data-intensive science. In 2021, Chris will
give the “Trends from the Trenches” presentation in its original “state-of-the-state address” followed by guest speakers giving podium talks on relevant topics. An interactive Q&A moderated discussion with the audience
follows. Come prepared with your questions and commentary for this informative and lively session. To stay connected with Trends from the Trenches updates after today and all year, sign up for BioTeam's newsletter here: https://bit.ly/33uO0OY
Chris Dagdigian, Senior Director, BioTeam, Inc.
Fernanda S. Foertter, PhD, Director of Applications, NextSilicon
Karl Gutwin, PhD, Director, Software Engineering Services, BioTeam, Inc.
Adam Kraut, Director Infrastructure & Cloud Architecture, BioTeam, Inc.